ABSCI
Live / Allowed — Approved for publication (as of 01 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99137299
- Mark type
- Stylized text
- Filed
- 15 Apr 2025
- Attorney of record
- Tiffany D. Gehrke
Goods and services
- Class 005 — Pharmaceuticals: cells for medical or clinical use; antibodies for the treatment of inflammatory and fibrotic diseases being antibodies for medical purposes
Owner
- Absci Corporation, Vancouver, WA, US
Prosecution history
- 01 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Jan 2026 — NON-FINAL ACTION E-MAILED
- 02 Jan 2026 — NON-FINAL ACTION WRITTEN
- 10 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Sept 2025 — NON-FINAL ACTION E-MAILED
- 12 Sept 2025 — NON-FINAL ACTION WRITTEN
- 10 Sept 2025 — ASSIGNED TO EXAMINER
- 15 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED